Skip to main content
Signal8

Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.

$PCRXPress releaseOct 30, 2026, 8:40 AM ETRead the release

Viatris, through its wholly owned subsidiary Peach Purchaser Sub Inc., commenced a tender offer to acquire all outstanding Pacira BioSciences shares for $36.50 per share in cash. The offer follows an Oct. 8, 2026 merger agreement and expires one minute after 11:59 p.m. ET on Nov.

Key figures

Deal Value Usd
$36.50 per share in cash
Offering Price
36.5
Offer expiry
Nov. 16, 2026, 11:59 p.m. ET (one minute after)
Minimum condition
shares tendered representing at least one more than 50% of outstanding shares
Financing condition
No
Merger agreement date
Oct. 8, 2026
Stockholder vote required
No

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.